The Oncology Brothers chat with Dr. Wallis on PARP inhibitors as well as neoadjuvant IO and EV for bladder cancer. Petros Grivas, MD, PhD, highlights the practice-changing studies that have come out of the ASCO GU 2023 Symposium. Neeraj Agarwal, MD, shares the standard-of-care treatment algorithms for localized prostate cancer, CSPC, and CRPC. Elizabeth Plimack, MD, MS, Deputy Director, Fox Chase Cancer Center, shares her approach to treating renal cell cancer. Andrea Apolo, MD, Chief of Bladder Cancer - Genitourinary Malignancy at the NCI, discusses bladder cancer treatment.